Changes in the immune-endocrine interrelationships in anxiety and depression

Stress Medicine

Volumn 13, Issue 4, 1997, Pages 217-227

  Leonard, Brian E ^a   Song, Cai ^b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Anxiety; CRF; Cytokines; Depression; Endocrine changes; Immune system; Neurotransmitters

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; GLUCOCORTICOID; NEUROTRANSMITTER;

ANXIETY NEUROSIS; CORTICOTROPIN RELEASE; DEPRESSION; ENDOCRINE SYSTEM; HUMAN; IMMUNE SYSTEM; LIMBIC SYSTEM; MENTAL STRESS; PSYCHOPHYSIOLOGY; REVIEW;

EID: 0030688931     PISSN: 07488386     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1700(199710)13:4<217::AID-SMI742>3.0.CO;2-I     Document Type: Review

References (76)

1. Rasmussen, A. F., Spencer, E. T. and Marsh, J. J. Decrease in susceptibility in mice to passive anaphylaxis following avoidance learning stress. Proc. Soc. Exp. Biol. Med. 1959; 100: 878-886.
2. Vessey, S. H. Effects of grouping on levels of circulating antibodies in mice. Proc. Soc. Biol. 1964; 1215: 252-258.
3. Hill, C. W., Greer, W. E. and Felsenfeld, O. Psychological stress: Early response to foreign protein and blood Cortisol in ferrets. Psychosom. Med. 1967; 29: 279-284.
4. Solomon, G. F., Allansmith, M., McClellan, B. and Ankraut, A. A. Immunoglobulins in psychiatric patients. Arch. Gen. Psychiat. 1969; 20: 272-277.
5. Laudenslager, M. L., Ryan, S. M., Drugan, R. C., Hyson, R. L. and Maier, S. R. Coping and immunosuppression: Inescapable but not escapable shock suppress lymphocyte proliferation. Science 1983; 221: 568-570.
6. Song, C. and Leonard, B. E. The effect of stressful behavioural exposure and endocrine and immune parameters in the rat. Stress Med. 1994;
7. Schlier, S. J., Keller, S. E., Cameriu, M., Thornton, C. J. and Stein, M. Suppression of lymphocyte Stimulation following bereavement. JAMA 1983; 250: 374-377.
8. Clayton, P. J., Halikes, J. A. and Maurice, W. L. The depression of widowhood. Brit. J. Psychiat. 1972; 120: 71-80.
9. Bistrian, B. R., Blackburn, G. L. and Serimshow, N. S. Cellular immunity in semi-starved states in hospitalized adults. Am. J. Clin. Nutrit. 1975; 28: 1148-1155.
10. Richie, J. C. and Nemeroff, C. B. Stress, the hypothalamic-pituitary-adrenal axis and depression. In: Stress, Neuropeptides and Systemic Disease. McCubbin, J. A., Kaufmann, P. G. and Nemeroff, C. B. (Eds) Academic Press, New York, 1991, pp. 187-197.
11. Donald, R. A., Redekop, C., Cameron, V. and Nicholls, M. G. The hormonal actions of corticotropin-releasing factor in sheep: Effect of intravenous and intracerebroventricular injection. Endocrinol. 1983; 113: 886-870.
12. Gertz, B. J., Contrevas, L. N., McComb, D. J., Kovacs, K., Tyrrell, J. B. and Dallman, M. F. Chronic administration of corticotropin-releasing factors increases pituitary corticotroph number. Endocrinol. 1987; 120: 381-388.
13. Gagner, J. P. and Drouin, J. Opposite regulation of pro-opiomelanocortin gene transcription by glucocorticoids and CRH. Mol. Cell. Endocrinol. 1985; 40: 25-32.
14. Jones, M. T. and Hillhouse, E. W. Structure-activity relationship and the mode of action of corticosteroid feedback and the secretion of corticotropin-releasing factor. J. Steroid. Biochem. 1976; 7: 1189-1202.
15. Fisher, L. A. and Brown, M. R. Corticotropin releasing factor and angiotensin II: Comparison of CNS actions to influenced neuroendocrine and cardiovascular function. Brain Res. 1984; 296: 41-47.
16. Song, C. and Leonard, B. E. Behavioural, neurochemical and immunological responses to CRF administration: Is CRF a mediator of Stressor anxiety response? (Submitted for publication)
17. Chappell, P. B., Smith, M. A., Kilts, C. D. and Bissette, G. Alterations in CRF-like immunoactivity in discrete brain regions after acute and chronic stress. J. Neurosci. 1986; 2908-2914.
18. Livnat, S., Felten, S. Y., Carlson, S. L., Bellinger, D. L. and Felten, D. L. Involvement of central and peripheral catecholamine systems in neural-immune interactions. J.Neuroimmunol. 1985; 10: 5-30.
19. Felten, D. L., Felten, S. Y., Carlson, S. O., Olschowska, J. A. and Livnat, S. Noradrenergic and peptidergic innervation of lymphoid tissue. J. Immunol. 1985; 135: 755S-765S.
20. Leonard, B. E. Stress and the immune system: Immunological aspects of depressive illness. In: Stress, the Immune System and Psychiatry. Leonard, B. E. and Miller, K. (Eds) Wiley, Chichester, 1994, pp. 113-136.
21. Pawlikowski, M., Zelazowski, P., Dohler, K. D. and Stepien, H. Effects of two neuropeptides: Somatolibrin (GRF) and corticolibrin (CRF) on human natural killer cell activity. Brain Behav. Immun. 1988; 2: 50-56.
22. Stepien, H., Zelazowski, P., Pawlikowski, M. and Dohler, K. P. CRF suppression of human peripheral blood leukocyte chemotaxis. Neuroendocrin. Lett. 1987; 9: 225-230.
23. Irwin, M. R., Vale, W. and Britton, J. K. J. Central corticotropin releasing factor suppresses natural killer cell toxicity. Brain Behav. Immunol. 1987; 1: 81-87.
24. Webster, E. L., Tracey, D. E., Jutila, M., Wolfe, S. A. and De Suza, E. B. CRF receptors in mouse spleen: Identification of receptor bearing cells as resident macrophages. Endocrinol. 1990, 127: 440-452.
25. Song, C., Kelly, J. and Leonard, B. E. Is the state of leucocyte adhesiveness/aggregation an immune marker of stress in the olfactory bulbectomized rat? Stress Med. 1993; 9: 255-258.
26. Song, C. and Leonard, B. E. CRF as a stress hormone. Ann. NY Acad. Sci. 1994;
27. Adamec, R. E., Sayni, U. and Brown, A. The effects of CRF and handling stress on behaviour in the elevated plus maze test of anxiety. J. Psychopharmac. 1991; 5: 175-186.
28. Van Riezen, H. and Leonard, B. E. Effects of psychotropic drugs on the behaviour and neurochemistry of olfactory bulbectomized rats. Pharm. Ther. 1990; 47: 21-34.
29. Leonard, B. E. Stress and the immune system: Immunological aspects of depressive illness. In: Stress, the Immune System and Psychiatry. Leonard, B. E. and Miller, K. (Eds) Wiley, Chichester, 1994, pp. 113-136.
30. O'Neill, B. and Leonard, B. E. Abnormal zymosan-induced neutrophil chemiluminescence as a marker of depression. J. Affect. Disord. 1990; 19: 265-272.
31. Song, C. and Leonard, B. E. Serotonin reuptake inhibitors reverse the impairments in behaviour, neurotransmitter and immune function in the olfactory bulbectomized rat. Hum. Psychopharmac. 1994; 9: 135-146.
32. Singh, V. K., Warren, R. P., White, E. D. and Len, S. J. CRF induced stimulation of immune functions. Ann. NY Acad. Sci. 1990; 594: 416-419.
33. Song, C., Curran, C. and Leonard, B. E. The effect of interleukin 2 on mitogen-stimulated lymphocyte proliferation in the olfactory bulbectomized rat model of depression. Med. Sci. Res. 1993; 21: 449-450.
34. Moynihan, J. A., Cohen, N. and Ader, R. Stress and immunity. In: Neuropeptides and Immunoregulation. Scharrer, B., Smith, E. M. and Stefano, G. B. (Eds) Springer-Verlag, Berlin, 1994, pp. 120-138.
35. Richardson, G. S. and Martin, J. B. Circadian rhythms in neuroendocrinology and immunology: Influence of ageing. Prog. Neuroendocrinimmunol. 1988; 1: 16-20.
36. Richie, J. C. and Nemeroff, C. B. Stress, the hypothalamic-pituitary-adrenal axis, the depression. In: Stress, Neuropeptides and Systemic Disease. McCubbin, J. A., Kaufmann, P. G. and Nemeroff, C. B. (Eds) Academic Press, New York, 1991, pp. 181-198.
37. France, R. D., Urban, B., Krishnan, K. R., Bissette, G., Banki, C. M., Nemeroff, C. and Speilman, F. J. CRF-like immunoreactivity in chronic pain patients with and without major depression. Biol. Psychiat. 1988; 23: 86-88.
38. Avato, M., Banki, C. M., Bissette, G. Nemeroff, C. B. Elevated CSF concentrations of CRF in suicide victims. Biol. Psychiat. 1989; 25: 355-359.
39. Nemeroff, C. B., Owens, M. J., Bissette, G., Andorn, A. C. and Stanley, M. Reduced CRF binding sites in the frontal cortex of suicides. Arch. Gen. Psychiat. 1988; 45: 577-579.
40. Nemeroff, C. B., Bissette, G., Akil, H. and Fink, M. CSF neuropeptides in depressed patients treated with ECT: CRF, beta endorphin and somatostatin. Brit. J. Psychiat. 1991; 158: 59-63.
41. Onsrud, M. Influence of in vivo hydrocortisone on some human blood leukocyte sub-populations. II Effects of T-cell monocyte cooperation. Acta Pathol. Microbiol. Scan. 1987; 89: 321-327.
42. Kelso, A. and Munck. A. Glucocorticoid inhibition of lymphokine secretion by alloreactive T-lymphocyte clones. J. Immunol. 1984; 133: 784-791.
43. Sachar, E. J. Endocrine abnormalities in depression. In: Handbook of Affective Disorders. Paykel, E. S. (Ed.) Guilford, New York, 1982, pp. 191-201.
44. Kronfol, Z., Nasrallah, H. A., Chapman, S. and House, J. D. Depression, cortisol metabolism and lymphocytopenia. J. Affect. Disord. 1985; 9: 169-173.
45. Murphy, D., Gardner, R., Greden, I. F. and Caroll, B. Lymphocyte numbers in endogenous depression. Psychol. Med. 1987; 17: 381-385.
46. Syvalahti, E., Eskola, J., Ruuskanen, O. and Laine, T. Non-suppression of cortisol in depression and immune function. Prog. Neuro-Psychopharm. Biol. Psychiat. 1985; 9: 413-422.
47. Halbreich, U., Naor, S., Asnis, G., Gasparini, F., Goldstein, S., Vital-Herne, J. and Kang, B. J. Decreased dexamethasone suppression in endogenously depressed patients with normal basal plasma levels of cortisol. Biol. Psychiat. 1986; 21: 1434-1437.
48. Gormley, G. J., Lowry, M. T., Reder, A. T., Hospelhorn, V. D., Antel, J. P. and Meltzer, H. Y. Glucocorticoid receptors in depression: Relationship to the dexamethasone suppression test. Am. J. Psychiat. 1985; 142: 1278-1284.
49. Whalley, L. J., Borthwick, N., Copolov, D., Dick, H., Christie, J. E. and Fink, G. Glucocorticoid receptors and depression. Brit. Med. J. 1986; 292: 859-861.
50. Lowry, M. T. and Gormley, G. Immune function, glucocorticoid receptor regulation and depression. In: Depressive Disorders and Immunity. Miller, A. H. (Ed.) American Psychiatric Press, Washington, DC, 1989, pp. 105-133.
51. Miller, A. H., Asnis, G. M., Kackner, C. and Norin, A. J. The in vitro effect of cortisol on natural killer cell activity in patients with major depressive disorder. Psychopharmac. Bull. 1987; 23: 504-520.
52. Pepper, G. M. and Krieger, D. T. Hypothalamic-pituitary-adrenal abnormalities in depression: Their possible relation to central mechanisms regulatory ACTH release. In: Neurobiology of Mood Disorders. Post, R. M. and Ballenger, J. C. (Eds) Williams and Wilkins, Baltimore, 1984, pp. 234-270.
53. Sapolsky, R. M., Krey, L. C. and McEwen, B. S. Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response. Proc. Nat. Acad. Sci. 1984; 81: 6174-6177.
54. Irwin, M., Daniels, M., Risch, S. C., Bloo, E. and Weiner, H. Plasma cortisol and natural killer cell activity during bereavement. Biol. Psychiat. 1988; 24: 173-178.
55. McEwen, B. S., Davis, P. G. and Parsons, B. The brain as a target for steroid hormone action. Ann. Rev. Neurosci. 1979; 2: 65-112.
56. Reul, J. M. H. M. and De Kloet, E. R. Anatomical resolution of two types of corticosterone receptor sites in rat brain with in vitro auto-radiography and computerized image analysis. J. Steroid. Biochem. 1986; 24: 269-272.
57. Van Eckelen, J. A. M., Kiss, J. Z., Westphal, H. M. and De Kloet, E. R. Immuno-cytochemical study on the intracellular localization of the type 2 glucocorticoid receptor in the rat brain. Brain Res. 1987; 436: 120-128.
58. Nemeroff, C. B., Owens, M. J. and Bisette, G. Reduced corticotropin releasing factor binding site in frontal cortex of suicide victims. Arch. Gen. Psychiat. 1988; 45: 577-579.
59. Gold, P., Kling, M. A. and Demitrck, M. A. Clinical studies with corticotropin releasing hormone: Implications for the hypothalamic pituitary adrenal dysfunction in depression and related disorders. In: Current Trends in Neuroendocrinology, Genten, D. and Pfaff, D. (Eds) Springer-Verlag, Berlin, 1988, Vol. 8.
60. Gatti, G., Masera, R. G., Pallavicini, L., Sartori, M. L., Stauenghi, A., Orlandi, F. and Angeli, A. Interplay in vivo between ACTH, beta-endorphin and glucocorticoids in the modulation of spontaneous and lymphokine-inducible human natural killer cell activity. Brain Behav. Immun. 1993; 7: 16-28.
61. De Kloet, E. R., Kovacs, G. L. and Szabo, G. Decreased serotonin turnover in the dorsal hippocampus of rat brain shortly after adrenalectomy: Selective normalization after corticosterone substitution. Brain Res. 1982; 239: 659-663.
62. De Kloet, E. R., Sybesma, H. and Reul, J. M. H. M. Selective cortisol by corticosterone of serotonin-1 receptor capacity in raphe-hippocampal system. Neuroendocrinol. 1986; 42: 513-521.
63. Kelly, W. F., Checkley, S. A. and Bender, D. A. Cushing's syndrome, tryptophan and depression. Brit. J. Psychiat. 1980; 136: 125-132.
64. Kelly, W. F., Checkley, S. A., Bender, D. A. and Mashiter, K. Cushing's syndrome and depression - a prospective study of 26 patients. Brit. J. Psychiat. 1983; 142: 16-19.
65. Kramlinger, K. G., Peterson, G. C., Watson, P. K. and Leonard, L. L. Metyrapone for depression and delirium secondary to Cushing's syndrome. Psychosomatics 1985; 26: 67-71.
66. Pepin, M. C., Beauluin, S. and Bardin, N. Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neuronal cultures. Mol. Brain Res. 1989; 6: 77-83.
67. Berkenbosch, F., Van Oers, J., del Rev., A., Tilders, F. and Besedovsky, H. Corticotropin-releasing factor producing neurons in the rat activated by interleukin 1, Science 1987; 238: 524-526.
68. Sapolsky, R., Rivier, C., Yamamoto, G., Plotsky, P. and Vale, W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 1987; 238: 522-524.
69. Kabiersch, A., Del Rey, A., Honegger, C. G. and Besedovsky, H. Interleukin-1 induces changes in norepinephrine metabolism in the rat brain. Brain Behav. Immun. 1988; 2: 267-274.
70. Palazzolo, D. L. and Quadri, S. K. Interleukin-1 stimulates catecholamine release from the hypothalamus. Life Sci. 1990; 47: 2105-2109.
71. Nair, M. P. N., Schwartz, S. A., Wu, K. and Kronfol, Z. Effects of neuropeptide Y on natural killer activity of normal human lymphocytes. Brain Behav. Immun. 1993; 7: 70-78.
72. Maes, M., Bosmans, E., Vandervorwst, C., De Jonckheere, C. and Raus, J. Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production. Acta Psychiatr. Scand. 1991; 84: 379-386.
73. Serio, R. and Daniel, E. E. Eicosanoids and peripheral neurotransmission. Prostaglandins, leukotrienes and essential fatty acids. Reviews 1989; 38: 237-246.
74. Smith, R. S. The macrophage theory of depression. Med. Hypothesis 1991; 35: 298-306.
75. Dantzer, R. and Kelly, K. W. Stress and immunity: An integrated view of relationships between the brain and the immune system. Life Sci. 1989; 44: 1995-2008.
76. Armani, D., Witzgall, H., Strasser, T. and Weber, P. C. Mineralocorticoid and glucocorticoid receptors in circulating mononuclear leukocytes of patients with primary hyperaldosteronism. Cardiology 1985; 72:99-101.